Free Trial
One Day Left! MarketBeat All Access Returns to $249 Soon
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Don't Miss Out
Claim MarketBeat All Access Sale Promotion

Abbott Laboratories (ABT) Earnings Date, Estimates & Call Transcripts

Abbott Laboratories logo
$103.87 +1.23 (+1.20%)
As of 11:25 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Abbott Laboratories Earnings Summary

Abbott Laboratories announced Q3 2026 earnings on October 21, 2026, reporting an EPS of $1.42, which met analysts' consensus estimates of $1.42. Quarterly revenue rose 14.5% year-over-year to $13.01 billion, above analyst estimates of $12.99 billion. With a trailing EPS of $2.68 and a P/E Ratio of 38.66, Abbott Laboratories' earnings are expected to grow 7.79% next year, from $5.52 to $5.95 per share.

Latest Q3
Earnings Date
Oct. 21Estimated
Consensus EPS
(Oct. 21)
$1.42
Actual EPS
(Oct. 21)
$1.42
Actual Revenue
(Oct. 21)
$13.01B

Q3 2026 Earnings Resources

Get Abbott Laboratories Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Abbott Laboratories and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ABT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ABT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Abbott Laboratories Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS Guidance
Q1 20262$1.14$1.19$1.171.120 - 1.180
Q2 20262$1.37$1.38$1.381.250 - 1.310
Q3 20262$1.45$1.45$1.451.380 - 1.46
Q4 20262$1.66$1.69$1.68
FY 20268$5.62$5.71$5.67
Q1 20271$1.25$1.25$1.25
Q2 20271$1.51$1.51$1.51
Q3 20271$1.62$1.62$1.62

Abbott Laboratories Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
10/21/2026Q3 2026$1.42$1.42-$0.53$12.99B$13.01B
7/16/2026Q2 2026$1.28$1.31+$0.03$0.53$12.52B$12.59B
4/16/2026Q1 2026$1.14$1.15+$0.01$0.61$10.99B$11.16B
1/22/2026Q4 2025$1.50$1.50-$1.01$11.80B$11.46B
10/15/2025Q3 2025$1.30$1.30-$0.94$11.40B$11.37B
7/17/2025Q2 2025$1.26$1.26-$1.01$11.01B$11.14B
4/16/2025Q1 2025$1.07$1.09+$0.02$0.76$10.38B$10.36B
1/22/2025Q4 2024$1.34$1.34-$5.27$11.03B$10.97B

Abbott Laboratories Earnings - Frequently Asked Questions

Abbott Laboratories (NYSE:ABT) last announced its quarterly earning data on Wednesday, October 21, 2026. Learn more on ABT's earnings history.

In the previous quarter, Abbott Laboratories (NYSE:ABT) reported $1.42 earnings per share (EPS) to hit the analysts' consensus estimate of $1.42. Learn more on analysts' earnings estimate vs. ABT's actual earnings.

The conference call for Abbott Laboratories' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Abbott Laboratories' latest earnings report can be read online.
Read Transcript

Abbott Laboratories (NYSE:ABT) has a recorded annual revenue of $48.23 billion.

Abbott Laboratories (NYSE:ABT) has a recorded net income of $6.52 billion. ABT has generated $2.68 earnings per share over the last four quarters.

Abbott Laboratories (NYSE:ABT) has a trailing price-to-earnings ratio of 38.31 and a forward price-to-earnings ratio of 18.60. The price/earnings-to-growth ratio is 1.82.

Abbott Laboratories' earnings are expected to grow from $5.52 per share to $5.95 per share in the next year, which is a 7.79% increase.


Earnings data for NYSE:ABT is sourced from Fiscal.ai, with the most recent quarter reported on 10/21/2026. New results are added as companies report their earnings.
From Our Partners